Replies to post #337667 on Anavex Life Sciences Corp (AVXL)

[LBSR TO DA MOON]

FWIW - Based upon the $42M in expenses that AVXL just reported for the past fiscal year, they spend about $5.25M every 1 1/2 months. Assuming they raised $2M for the 1 1/2 month period from Sept. 30 - Nov. 19, they are well short of keeping pace with their expenditures so that cash runway will decrease if they keep that same pace of dilution going. No problem with cash runway decreasing if revenue is on the horizon. Bring on the revenue! Hopefully by late 2022, certainly no later than sometime in 2023...right?

Quote:
Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date: 76,018,053 issued and outstanding as of November 19, 2021
Quote:
As at September 30, 2021 Issued and outstanding: 75,918,465

76,018,053 - 75,918,465 = 99,588 shares were sold since the fiscal year end raising a couple of million dollars. All as per usual maintaining at present about 5 years of runway.